Intrexon | XON - Market Capitalization


Intrexon reported $1.01B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 128M 21M Mar/2026
Alaunos Therapeutics USD 6M 1000K Jun/2026
Amgen USD 247.94B 20.06B Nov/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 24.6B 1.95B Sep/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Ligand Pharmaceuticals USD 6.23B 108M Sep/2026
MacroGenics USD 151M 143M Nov/2026
MannKind USD 1.02B 237M Nov/2026
Merck USD 375.59B 17.09B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Roche Holding CHF 270B 3.66B Jun/2026
Thermo Fisher Scientific USD 249.58B 58.93B Sep/2026
Veracyte USD 4.12B 414M Nov/2026
Xencor USD 2.14B 281M Nov/2026